Eleutherococcus senticosus (Rupr. and Maxim.) Maxim. (Araliaceae) as an adaptogen: A closer look

Journal of Ethnopharmacology

Volumn 72, Issue 3, 2000, Pages 345-393

  Davydov, Marina ^a   Krikorian, A D ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

'Siberian ginseng'; Adaptogen; Adaptogenic activity; Anti cancer agents; Anti oxidants; Eleutherococcus senticosus; Lignans; Panax ginseng; Placebo effect; Saponins; True ginseng

Indexed keywords

ALVITA; CAFFEIC ACID; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; GINSENG; GINSENOSIDE RB 1; GINSENOSIDE RB 3; GINSENOSIDE RB 4; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RF; GINSENOSIDE RG 1; GINSENOSIDE RG 2; GINSENOSIDE RG 3; GINSENOSIDE RH 1; GINSENOSIDE RH 2; HEDERASAPONIN B; ISOFRAXIDIN; KONSTITUTIN FORTE; NATROL; NATURES HERBS; NATURES WAY; PLANT EXTRACT; PROTAPANAXADIOL; SESAMIN; SITOGLUSIDE; SITOSTEROL; SYRINGIN; TOTAL SPECTRUM; TROPFEN; UNCLASSIFIED DRUG; ZAND;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; BILE FLOW; CHEMICAL COMPOSITION; DRUG ACTIVITY; ETHNOPHARMACOLOGY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; IMMUNOSTIMULATION; IMPOTENCE; LEISHMANIASIS; MOUSE; NONHUMAN; RADIATION PROTECTION; REVIEW; STRESS;

ANIMAL; HUMAN; PANAX; PLANT EXTRACTS; PLANTS, MEDICINAL;

ELEUTHEROCOCCUS SENTICOSUS;

EID: 0033805268     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(00)00181-1     Document Type: Review

References (200)

1. Akimoto K., Kitagawa Y., Akamatsu T., Hirose N., Sugano M., Shimazu S., Yamada H. Protective effect of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Annals of Nutrition and Metabolism. 37(4):1993;218-224.
2. Akzhigitov G.N., Benumovich M.S., Chikorin A.K. English-Russian Medical Dictionary. second ed. 1992;Russkiy Yazyk Publishers, Moscow.
3. Ambasta, S.P. (Ed.), 1986. The Useful Plants of India. Publications & Information Directorate. Council of Scientific & Industrial Research, New Delhi.
4. Asano K., Takahashi T., Miyashita M., Muramatsu S., Kunoyama M., Kugo H., Imai J. Effect of Eleutherococcus senticosus extract on human physical working capacity. Planta Medica. 52:1986;175-177.
5. Astin J.A. Why patients use alternative medicine. Journal of the American Medical Association. 279:1998;1548-1553.
6. Atal C.K., Schwarting A.E. Ashwagandha - an ancient Indian drug. Economic Botany. 15:1961;256-263.
7. Awad A.B., Von Holtz R., Cone J.P., Fink C.S., Chen Y.C. β-sitosterol inhibits growth of HT-29 human cancer cells by activating the sphingomyelin cycle. Anticancer Research. 18(1A):1998;471-479.
8. Ayres D.C., Loike J.D. Lignans: Chemical, Biological and Clinical Properties. 1990;Cambridge University Press, Cambridge.
9. Aziz N.H., Farag S.E., Mousa L.A., Abo-Zaid M.A. Comparative antibacterial and antifungal effects of some phenolic compounds. Microbios. 93(374):1998;43-54.
10. Bahrke M.S., Morgan W.P. Evaluation of the ergogenic properties of ginseng. Sports Medicine. 18:1994;229-248.
11. Baranov A.I. Medicinal uses of ginseng and related plants in the Soviet Union: recent trends in the Soviet literature. Journal of Ethnopharmacology. 6:1982;339-353.
12. Barrett S. 'Alternative medicine': more hype than hope. Humber J.M., Almeder R.F. Alternative Medicine and Ethics. 1998;3-41 Humana Press, Totowa, NJ.
13. Bensky D., Barolet R. Chinese Herbal Medicine: Formulas and Strategies. 1990;Eastland Press, Seattle.
14. Bensky D., Gamble A. Chinese Herbal Medicine. 1986;Materia Medica, Eastland Press, Seattle.
15. Bhatnagar, S.S. et al. (Eds.), 1948-1976. The Wealth of India. Raw Materials. Delhi, Council of Scientific and Industrial Research.
16. Bivins R. The body in balance: medicine and dynamic equilibrium. Porter R. Medicine. A History of Healing. Ancient Traditions to Modern Practices. 1997;94-117 Marlowe & Company, NY.
17. Bladt S., Wagner H., Woo W.S. Taiga-Wurzel. DC- und HPLC-Analyse von Eleutherococcus-bzw. Acanthopanax-Extrakten und diese enhaltenden Phytopräparaten. Deutsche Apotheker Zeitung. 130:1990;1499-1509.
18. Blumenthal, M., Busse, W.R., Goldberg, A., Gruenwald, J., Hall, T., Riggins, C.W., Rister, R.S. 1998. The Complete German Commission E Monographs. Therapeutic guide ti Herbal Medicines. Primary translator; Sigrid Klein, Associate translator; Robert S. Rister. American Botanical Council: Austin, Texas; Integrative Medicine Communications, Boston, MA.
19. Borris R.P., Cordell G.A., Farnsworth N.R. Isofraxidin, a cytotoxic coumarin from Micrandra elata (Euphorbiaceae). Journal of Natural Products. 43:1980;641-643.
20. Braun, A.C., 1969. The cancer problem. A Critical Analysis and Modern Synthesis, 1969. Columbia University Press, NY.
21. Braun A.C. The Biology of Cancer. 1974;Addison-Wesley Publishing Company, London.
22. Braun, A.C., 1977. The Story of Cancer. On Its Nature, Causes, and Control. Addison-Wesley Publishing Company, London.
23. Brekhman I.I. Eleutherokokk (Eleutherococcus). 1968;Nauka Publishing House, Leningrad, USSR. in Russian.
24. Brekhman I.I. Chelovek i biologicheski aktivnye vezshestva (Man and Biologically Active Substances). 1976;Nauka Publishing House, Leningrad, USSR. in Russian.
25. Brekhman, I.I., 1980. Man and Biologically Active Substances. The Effect of Drugs, Diet and Pollution on Health. Pergamon Press, Oxford.
26. Brekhman I.I., Dardymov I.V. New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology. 9:1969;419-430.
27. Bretschneider, E., 1898. [1962 facsimile reprint of 1898 original edition]. History of European Botanical Discoveries in China. Zentral-Antiquariat der Deutschen Demokratischen Republic Leipzig.
28. Carlson A.W. Ginseng: America's botanical drug connection to the Orient. Economic Botany. 40:1986;233-249.
29. Carson, G., 1961. One for a Man, Two for a Horse. A pictorial history, grave and comic, of patent medicines. Doubleday & Company, Garden City, NY.
30. Casey D.E. Side effect profiles of new antipsychotic agents. Journal of Clinical Psychiatry. 57(Suppl. 11):1996;40-45.
31. Chadha, Y.R. (Ed.), 1985. The Wealth of India, Volume 1. Publications and Information Directorate. CSIR, New Delhi.
32. Chan W.S., Wen P.C., Chiang H.C. Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition. Anticancer Research. 15:1995;703-707.
33. Chemexcil, 1992. Selected Medicinal Plants of India. A Monograph on Identity, Safety and Clinical Usage. Basic Chemicals, Pharmaceuticals & Cosmetics Export Promotion Council. Thansi Castle, 7, Cooperage Road, Bombay.
34. Chen J.Y.P. Chinese health foods and herb tonics. American Journal of Chinese Medicine. 1:1973;147-225.
35. Chong S.K.F., Oberholzer V.G. Ginseng - is there a use in clinical medicine? Postgraduate Medical Journal. 64:1988;841-846.
36. Clouser, K.D., Culver, C.M., Gert, B., 1997. Malady. In: Humber, J.M., Almeder, R.F. (Eds.) What is Disease? Biomedical Ethics Reviews Series, Georgia State University, Atlanta, GA, pp. 175-217.
37. Cotran R.S., Kumar V., Robbins S.L., Schoen F.J. Pathological Basis of Disease. Fifth ed. 1994;WB Saunders Company, Philadelphia.
38. Court W.E. The doctrine of signatures or similitudes. Trends in Pharmacological Sciences. 6:1985;225-227.
39. Daley L., Guminski Y., Demerseman P., Kruczynski A., Etievant C., Imbert T., Hill B.T., Monneret C. Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611. Journal of Medicinal Chemistry. 41:1998;4475-4485.
40. Danielak R., Popowska E., Borkowski B. The preparation of vegetable products containing isofraxidin, silibin, and Glaucium alkaloids and evaluation of their choleretic action. Polish Journal of Pharmacology and Pharmacy. 25(3):1973;271-283.
41. Dardymov I.V. Zhenshen, eleuterokokk (K mekhanismu biologicheskogo deistviya) [Gingseng, eleutherococcus, Mechanism of Biological Action]. 1976;Nauka Publishing House, Moscow, USSR. in Russian.
42. D'iakova S.D., Rudenko L.P. Dinamika individual'nogo predpochteniya v veroyatnosti i otsenka usileniya v razvitii eksperimental'nogo nevroza [The dynamics of individual preference in the probability and value of reinforcement in the development of experimental neurosis]. Zhurnal Vysshei Nervnoi Deiatel'nosti imeni I. Pavlova. 43:1993;443-453. in Russian.
43. Dixon A.R., McMillen H., Etkin N.L. Ferment this: the transformation of Noni, a traditional Polynesian medicine. Economic Botany. 53:1999;51-68.
44. Donelli M.G., Zucchetti M., Munzone E., D'Incalci M., Crosignani A. Pharmacokinetics of anticancer agents in patients with impaired liver function. European Journal of Cancer. 34:1998;33-46.
45. Duke J. Ginseng. A Concise Handbook. 1989;Reference Publications, Algonac, MI.
46. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., van Rampay M., Kessler R.C. Trends in alternative medicine use in the United States, 1990-1997. Journal of the American Medical Association. 280:1998;1569-1575.
47. Fahim M.S., Fahim Z., Harman J.M., Clevenger T.E., Mullins W., Hafez E.S. E. Effect of Panax ginseng on testosterone level and prostate in male rats. Archives of Andrology. 8:1982;261-263.
48. Fang J.-N., Proksch A., Wagner H. Immunologically active polysaccharides of Acanthopanax senticosus. Phytochemistry. 24:1985;2619-2622.
49. Farnsworth N.R., Kinghorn A.D., Soejarto D., Waller D.P. Siberian ginseng (Eleutherococcus senticosus): current status as an adaptogen. Economic and Medicinal Plant Research. 1:1985;155-215.
50. Franceschi S., Bidoli E., La Vecchia C., Talamini R., D'Avanzo B., Negri E. Tomatoes and risk of digestive-tract cancers. International Journal of Cancer. 59:1994;181-184.
51. Frank, J.D., Frank, J.B., 1991. Persuasion and healing. A comparative study of psychotherapy. Johns Hopkins University Press, Baltimore.
52. Frieden J. Patent laws blamed for lack of needed research. Skin and Allergy News. 29(2):1999;72.
53. Fulder S. The drug that builds Russians. New Scientist. 21:1980a;576-579.
54. Fulder S. The Root of Being. Ginseng and the Pharmacology of Harmony. 1980b;Hutchinson, London.
55. Fulder S. The Book of Ginseng and Other Chinese Herbs for Vitality. 1993;Healing Arts Press, Rochester.
56. Futuyma D.J. Evolutionary Biology. second ed. 1986;Sinauer Associates, Sunderland, MA.
57. Garman, H., 1898. Ginseng, Its Nature and Culture. Kentucky Agricultural Experiment Station, University of Kentucky (Lexington, KY), Bulletin No. 78, 123-156, figures 1-11.
58. Giovannucci E., Ascherio A., Rimm E.B., Stampfer M.J., Colitz G.A., Willett W.C. Intake of carotenoids and retinol in relation to risk of prostate cancer. Journal of the National Cancer Institute. 87:1995;1767-1776.
59. Goldstein B. Ginseng: its history, dispersion, and folk tradition. American Journal of Chinese Medicine. 3:1975;223-234.
60. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. Oral sildenafil in the treatment of erectile dysfunction. The New England Journal of Medicine. 338:1998;1397-1404.
61. Grabley, S., Thiericke, R., (Eds.), 1999. Drug Discovery from Nature. Springer-Verlag, NY.
62. Graham S.A. The genera of Araliaceae in southern United States. Journal of the Arnold Arboretum. 47:1966;126-136.
63. Greenberg E.R., Sporn M.B. Antioxidant vitamins, cancer, and cardiovascular disease. The New England Journal of Medicine. 334:1996;1189-1190.
64. Grinevich, M.A., 1990. Informatsionnyi Poisk Perspectivnykh Lekarstvennykh Rastenii Opyt Izucheniya Traditsionnoi Meditsiny Stran Vostochnoi Aziis Pomozhshiu EVM (in Russian). [Information Search for Perspective Medicinal Plants. An Experience of Studies on the traditional medicine of Eastern Asia with the aid of computer]. Nauka Publishing House, Leningrad.
65. Grmek M.D. The concept of disease. Grmek M.D. Western Medical Thought from Antiquity to the Middle Ages. 1998;241-258 Harvard University Press, Cambridge, MA.
66. Gui Y., Guo Z., Ke S., Skirvin R.M. Somatic embryogenesis and plant regeneration in Acanthopanax senticosus. Plant Cell Reports. 9:1991;514-516.
67. Guogan Z., Yan J. Calcium channel blockage and anti-free-radical action of ginsenosides. Chinese Medical Journal. 110:1997;28-29.
68. Gupta M.B., Nath R., Srivastava N., Kishor K., Bhargava K.P. Anti-inflammatory and antipyretic activities of β-sitosterol. Planta Medica. 39:1980;157-163.
69. Gutteridge J.M. C., Halliwell B. Antioxidants in Nutrition, Health, and Disease. 1994;Oxford University Press, Oxford.
70. Halstead B.W., Hood L.L. Eleutherococcus. Siberian Ginseng: An Introduction to the Concept of Adaptogenic Medicine. 1984;Oriental Healing Arts Institute, Long Beach, CA.
71. Hardacre V. Woodland Nuggets of Gold: The Story of American Ginseng Cultivation. 1968;Vantage Press, NY.
72. Harding A.R. Ginseng and Other Medicinal Plants. 1908;AR Harding, Columbus, OH.
73. Harrington A. The Placebo Effect. An Interdisciplinary Exploration. 1997;Harvard University Press, Cambridge (MA).
74. Heinemann T., Axtmann G., VonBergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. European Journal of Clinical Investigation. 23:1993;827-831.
75. Hikino H., Takahashi M., Otake K., Konno C. Isolation and hypoglycemic activity of eleutherans A, B, C, D, E, F, and G: glycans of Eleutherococcus senticosus roots. Journal of Natural Products. 49:1986;293-297.
76. Hirata F., Fujita K., Ishikura Y., Hosoda K., Ishikawa H. Hypocholesterolemic effect of sesame lignan in humans. Atherosclerosis. 122:1996;135-136.
77. Hirose N., Doi F., Ueki T., Akazawa K., Chijiiwa K., Sugano M., Akimoto K., Shimizu S., Yamada H. Suppressive effect of sesamin against 7,12-dimethylbenz[a]-anthracene induced rat mammary carcinogenesis. Anticancer Research. 12:1992;1259-1265.
78. Howlett, C., Falla, P., Unbegaun, B. (Eds.), 1993. The Oxford Russian Dictionary. Oxford University Press, Oxford, NY.
79. Hsiao P.K. Traditional experience of Chinese herb medicine. Its application in drug research and new drug searching. Beal J.L., Reinhard E. Natural Products as Medicinal Agents. 1980;351-394 Hippokrates Verlag, Stuttgart.
80. Huang K.C. The Pharmacology of Chinese Herbs. 1993;CRC Press, Boca Raton, FL.
81. Humber, J.M., Almeder, R.F. (Eds.), 1998. Alternative Medicine and Ethics. Biomedical Ethics Reviews. Humanities Press, Totawa.
82. Ivorra M.D., D'Ocan M.P., Paya M., Villar A. Antihyperglycemic and insulin-releasing effect of β-sitosterol 3-β-D-glucoside and its aglycone, β-sitosterol. Archives of International Pharmacodynamics. 296:1988;224-231.
83. Jablonska S. Traditional therapies for the treatment of Condylomata acuminata (genital warts). Australian Journal of Dermatology. 39(Suppl. 1):1998;S2-4.
84. Jordao A.A. Jr, Silvera S., Figueredo J.F., Vannucchi H. Urinary excretion and plasma vitamin E levels in patients with AIDS. Nutrition. 14:1998;423-426.
85. Journal of Natural Toxins. A Journal for Research and Investigation on Toxins of Natural Origin, 1992. Alaken, Ft. Collins, CO.
86. Jung K.Y., Kim D.S., Oh S.R., Lee I.S., Lee J.J., Park J.D., Kim S.I., Lee H.K. Platelet activating factor antagonist activity of ginsenosides. Biological Pharmacology Bulletin. 21:1998;79-80.
87. Kains M.G. Ginseng. Its Cultivation, Harvesting, Marketing and its Market Value with a Short Account of its History and Botany. 1906;Orange Judd, NY.
88. Kamen B. Siberian Ginseng: Up-to-Date Research on the Fabled Oriental Tonic Herb. 1988;Keats Publishing, New Canaan, CT.
89. Kapil A., Sharma S. Immunopotentiating compounds from Tinospora cordifolia. Journal of Ethnopharmacology. 58:1997;89-95.
90. Kaul A., Khanduja K.L. Polyphenols inhibit promotional phase of tumorigenesis: relevance of superoxide radicals. Nutrition and Cancer. 32:1998;81-85.
91. Kim H.S., Hong Y.T., Jang C.G. Effect of ginsenosides Rg1 and Rb1 on morphine-induced hyperactivity and reinforcement in mice. Journal of Pharmaceutical Pharmacology. 50:1998;555-560.
92. Kim H.S., Hong Y.T., Oh K.W., Seong Y.H., Pheu H.M., Cho D.H., Oh S., Park W.K., Jang C.G. Inhibition by Rb1 and Rg1 of methamphetamine-induced hyperactivity, conditioned place preference and postsynaptic dopamine receptor superactivity in mice. General Pharmacology. 30:1998;783-789.
93. 2+ channels and membrane capacitance in rat adrenal chromaffin cells. Brain Research Bulletin. 46:1998;245-251.
94. Kim Y.C., Kim S.R., Markelonis G.J., Oh T.H. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. Journal of Neuroscience Research. 53:1998;426-432.
95. Kollerstrom J. Basic scientific research into the 'low-dose effect'. The British Homeopathic Journal. 71:1982;41-47.
96. Konoshima T. Anti-tumor-promoting activities of triterpenoid glycosides; cancer chemoprevention by saponins. Waller G.R., Yanasaki K. Saponins Used in Traditional and Modern Medicine. Advances in Experimental Medicine and Biology Series. 1996;87-100 Plenum Press, NY.
97. Konstantinova N.A., Makhan'kov V.V., Uvarova N.I., Samoshina N.F., Sova V.V., Mikhailova O.M. Issledovanie dinamiki biosinteza ginzenozidov v tsikle rosta kallusnoi kul'tury kletok zhe'shenya [Studying the dynamics of biosynthesis of ginsenosides in growth cycle of callus culture of gingseng]. Biotekhnologia. 9-10:1995;35-39.
98. Krikorian, A.D., 1998. Medicinal plants and tropical forests: Some orthodox and some not-so-orthodox musings. In: Nair, M.N.B., Ganapaythi, N. (Eds.), Medicinal Plants: Cure of the 21st Century. Biodiversity, Conservation and Utilization of Medicinal Plants. Proceedings of the Seminar UPM, Serdang, Malaysia October 15-16, 1998, Faculty of Forestry, University Putra Malaysia, Selangor Darul Ehsan, pp. 32-110.
99. Krochmal A., Krochmal C. A Guide to the Medicinal Plants of the United States. 1973;The Quadrangle, New York Times Book Co, NY.
100. Kupin V.I., Polevaya Y.B., Sorokin A.M. Povysherie immunonologicheskoi realctivnosti onkologicheskikh bolnykh s pomoshzhiu ekstrakta eleuterokokka [Immunostimulation in cancer patients with eleutherococcus extract]. Voprosy Onkologii (Moscow). 32:1986;21-26. . in Russian.
101. Lapchik, V.F., Ovodov, Y.S., 1969. Viznachennya kilkosti biologichno aktivnikh rechovin u sirovini eleuterokoku kolyuchogo [Determination of the amount of biologically active substances in the raw material and drug preparations of Eleutherococcus senticosus]. Vesnik Kievskogo Universiteta imeni T.H. Shevchenka (Seriya Biolohii) 11. Vishcha shkola Publishing House, Kiev, Ukraine.
102. Lawson, L.D., Bauer, R. (Eds.), 1998. Phytomedicines of Europe. Chemistry and Biological Activity. American Chemical Society, Washington, DC.
103. Lazarev N.V. Antiblastomogennye lekarstvennye sredstva [Anti-blastomogenic medicinal substances]. Voprosy Onkologii. 11:1955;48-54. in Russian.
104. Lee T. Achievements in materia medica during the Ming dynasty (1368-1643). Chinese Medical Journal. 74:1956;171-191.
105. Leung A.Y. Chinese Healing Foods and Herbs. 1984;AYSL, Glen Rock, New Jersey.
106. Leung A.Y., Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. second ed. 1996;John Wiley, New York, NY.
107. Lewis N.G. Plant phenolics. Alscher R.G., Hess J.L. 1993, Antioxidants in Higher Plants. 1993;135-170 CRC Press, Boca Raton Fl.
108. Lewis N.G., Davin L.B. Evolution of lignan and neolignan biochemical pathways. Ness W.D. American Chemical Society Symposium Series 40. 1994;202-246 American Chemical Society, Washington, DC.
109. Lewis W.H. Ginseng: A medical enigma. Etkin N.L. Isopentenoids and other Natural Products: Evolution and Function. Plants in Indigenous Medicine & Diet: Biobehavioral Approaches. 1986;290-305 Redgrave Publishing, Bedford Hills, New York.
110. Liberti L.E., DerMarderosian A. Evaluation of commercial ginseng products. Journal of Pharmaceutical Sciences. 67:1978;1487-1489.
111. Lui J.H.C., Staba E.J. Ginsenosides of various ginseng plants and selected products. Journal of Natural Products. 43:1980;340-346.
112. Ma C., Nakamura N., Miyashiro H., Hattori M., Shimotohno K. Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chemical Pharmaceutical Bulletin. 47:1999;141-145.
113. Majester-Savornin B., Elias R., Diaz-Lanza A.M., Balansard G., Gasquet M., Delmas F. Saponins of the ivy plant, Hedera helix, and their Leishmanicidic activity. Planta Medica. 57:1991;260-262.
114. Mashkovsky M.D. Lekarstvennye Sredstva [Medicinal Substances]. 1988;Meditsina Publishing House, Tashkent, Uzbekistan.
115. Mason J.B. Consequences of altered micronutrient status. Bennett J.C., Plum F. Cecil's Textbook of Medicine. 20th ed. 1996;WB Saunders Company, Philadelphia.
116. McKusick, V.A. (Ed.), 1998. Mendelian Inheritance in Man. A Catalog of Human Genes and Genetic Disorders. The Johns Hopkins University Press, Baltimore.
117. Miller L.G. Herbal medicinals. Archives of Internal Medicine. 158:1998;2200-2211.
118. Mogil J.S., Shin Y.H., McCleskey E.W., Kim S.C., Nah S.Y. Ginsenoside Rf, a trace component of ginseng root, produces antinociception in mice. Brain Research. 792:1998;218-228.
119. Morowitz H.J. Much ado about nothing. Hospital Practice. 17:1982;215-216.
120. Morris, C. (Ed.), 1992. Academic Press Dictionary of Science and Technology. Academic Press, Harcourt Brace Jovanovich, Publishers, San Diego, CA.
121. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 99:1999;1726-1732.
122. Mowrey D.B. Herbal Tonic Therapies. 1993;Keats Publishing, New Canaan, CT.
123. Müller V.K. English-Russian Dictionary. 1989;Russkiy Yazyk, Moscow.
124. Mulvihill M.L. Human Diseases. A Systematic Approach. third ed. 1991;Appleton and Lange, Norwalk, CT.
125. Nakata H., Kikuchi Y., Tode T., Hirata J., Kita T., Ishii K., Kudoh K., Nagata I., Shinomiya N. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Japanese Journal of Cancer Research. 89:1998;733-740.
126. Nakayama T., Yamada M., Osawa T., Kawakishi S. Inhibitory effect of caffeic acid ethyl ester on H2O2-induced cytotoxicity and DNA single-stranded breaks in Chinese hamsters V79 cells., Bioscience. Biotechnology and Biochemistry. 60:1996;316-318.
127. Nies A.S., Spielberg S.P. Principles of therapeutics. Hardman J.G., Limbird L.E. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 1996;43-62 McGraw-Hill, NY.
128. Niwa Y., Miyachi Y., Ishimoto K, Kanoh T. Why are some natural plant medicinal products effective in some patients and not in others with the same disease? Planta Medica. 57:1991;299-304.
129. Nonaka M., Yamashita K., Iizuka Y., Namiki M., Sugano M. Effects of dietary sesaminol and sesamin on eicosanoid production and immunoglobulin level in rats given ethanol., Bioscience. Biotechnology and Biochemistry. 61:1997;836-839.
130. O'Connor B.B. et al. Defining and describing complementary and alternative medicine. Alternative Therapies in Health and Medicine. 3(2):1997;49-57.
131. Ogasawara T., Chiba K., Tada M. Sesamum indicum L. (Sesame): in vitro culture, and the production of naphthoquinone and other secondary metabolites. Bajaj Y.P.S. Biotechnology in Agriculture and Forestry. Medicinal and Aromatic Plants X. 41:1998;366-393 Springer-Verlag, Berlin.
132. Osbourn A.E., Webben J.P., Melton R.E., Carter J.P., Daniels M.J. Saponins in plant disease. Recent Advances in Phytochemistry. 32:1998;1-15.
133. Ota T., Maeda M., Odashima S. Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured melanoma B16 melanoma cells. Journal of Pharmaceutical Sciences. 80:1991;1141-1146.
134. Packer L., Reznick A.Z., Landvik S. The role of vitamin E and other antioxidants in physical exercise. Frei B. Natural Antioxidants in Human Health and Disease. 1994;567-576 Academic Press, San Diego.
135. Park J.A., Lee K.Y., Oh Y.J., Kim K.W., Lee S.K. Activation of caspase-3 protease via Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Letters. 121:1997;73-81.
136. Patel V. Understanding the integration of alternative modalities into an emerging healthcare model in the United States. Humber J.M., Almeder R.F. Alternative Medicine and Ethics. 1998;43-95 Humana Press, Totowa, NJ.
137. Pavlov, I.I., 1927. (facsimile reprint 1960) Conditioned Reflexes. Translated and edited by Anrep, G.V. An Investigation of the Physiological Activity of the Cerebral Cortex. Dover, NY.
138. Peterhans E. Oxidants and antioxidants in viral diseases: metabolic regulation and autotoxicity. Frei B. Natural Antioxidants in Human Health and Disease. 1994;Academic Press, San Diego.
139. Phillipson J.D., Anderson L.A. Ginseng - quality, safety and efficacy? Pharmaceutical Journal. 232:1984;161-165.
140. Poynter, F.N.L., (Ed), 1963. Chemistry in the Service of Medicine. J.B. Lippincott Company, Philadelphia.
141. Proctor J.T.A., Bailey W.G. Ginseng: industry, botany, and culture. Horticultural Reviews. 9:1987;187-236.
142. Radtke J., Linseisen J., Wolfram G. Phenolsäurezufuhr Erwachsener in einem bayerischen Teilkollektiv der Nationalen Verzehrsstudie. Zeitschrift für Ernahrungswissenschaft. 37:1998;190-197.
143. Rätsch C. Plants of Love. The History of Aphrodisiacs and a Guide to Their Identification and Use. 1997;Ten Speed Press, Berkeley, CA.
144. Rege N.N., Thatte U.M., Dahaukar S.A. Adaptogenic properties of six Rasayana herbs used in Ayurvedic medicine. Phytotherapy Research. 13:1999;275-291.
145. Reynolds, J. (Ed.), 1996. Martindale: The Extra Pharmacopoeia, The Pharmaceutical Press, London, 31st ed.
146. Romeo, J.T., Saunders, J.A., Barbosa, P. (Eds.), 1996. Phytochemical diversity and redundancy in ecological interactions. Recent Advances in Phytochemistry 30, Proceedings held in Sault Ste Marie, Ontario, Canada, 12-16 August 1995.
147. Root-Bernstein, R.M., Root-Bernstein, M., 1997. Honey, mud, maggots, and other medical marvels. The Science Behind Folk Remedies and Old Wives Tales. Houghton Mifflin, Boston.
148. Rothschild, H. (Ed.), 1981. Biocultural Aspects of Disease. Academic Press.
149. Rothstein W.G. Movements and orthodox medicine. Gevitz N. Other Healers. Unorthodox Medicine in America. 1988;29-51 The Johns Hopkins University Press, Baltimore.
150. Ruijun Z., Jinkang Q., Gnanghua Y., Baozhen W., Xiulan W. Medicinal protection with Chinese herb-compound against radiation damage. Aviation, Space and Environmental Medicine. 61:1990;729-731.
151. Sahelian R. Kava. The Miracle Antianxiety Herb. 1998;St. Martin's Paperbacks, NY.
152. Saks M. East meets west. The emergence of holistic tradition medicine. Porter R. A History of Healing. Ancient Traditions to Modern Practices. 1997;196-219 Marlowe & Company, NY.
153. Sanglier J.J. Immunosupressants from natural sources. Mukherjee B., Tripathi S.K., Bhunia S.K., Mukherjee B. Traditional Medicine. 1993;Science Publishers, Lebanon, NH.
154. Scahill L., Skrypeck A. The use of traditional neuroleptics in children and adolescents. Journal of Adolescent Psychiatric Nursing. 10:1997;41-45.
155. Shahidi, F. (Ed.), 1997. Natural Antioxidants. Chemistry, Health Effects, and Applications. AOCS Press, Champaign, Il.
156. Shapiro A.K., Shapiro E. The Powerful Placebo: From Ancient Priest To Modern Physician. 1997;Johns Hopkins University Press, Baltimore.
157. Shibata S., Tanaka O., Shoji J., Saito H. Chemistry and pharmacology of Panax. Economic and Medicinal Plant Research. 1:1985;217-284.
158. Sies H. Oxidative stress: from basic research to clinical medicine. Favier A.E., Néve J., Faure P. Trace Elements and Free Radicals in Oxidative Diseases. 1994;1-7 AOCS Press, Champaign, IL.
159. Singer S.R. Current status of the U.S. ginseng export program. Endangered Species Technical Bulletin. 15(1):1990;9.
160. Sivarajan V.V., Balachandran I. Ayurvedic Drugs and their Plant Sources. 1994;International Science Publisher, Lebanon, NH.
161. Sjöqvist F. Interindividual differences in drug responses: an overview. Rowland M., Sheiner L.B., Steimer J.-L. Variability in Drug Therapy. Description, Estimation, and Control. A Sandoz Workshop. 1985;1-9 Raven Press, NY.
162. Soejarto D.D., Farnsworth N.R. The correct name for Siberian ginseng., Harvard University. Botanical Museum Leaflets. 26:1978;339-343.
163. Sokolov S.Y., Zamotaev I.P. Spravochnik po Lekarstvennym Rasteniyam. Fitoterapiya [Reference Book on Medicinal Plants]. 1990;Meditsina Publishing House, Moscow.
164. Soliman, K.F.A., Mazzio, E.A., 1998. In vitro attenuation of nitric acid production in C6 astrocyte cell culture by various dietary compounds. Proceedings of Society of Experimental Biology and Medicine 218, 390-397.
165. Sonnenborn U., Hänsel R. Eleutherococcus senticosus. De Smet P.A.G.M., Keller K., Hänsel R., Chandler R.F. Adverse Effects of Herbal Drugs. 2:1993;159-169 Springer-Verlag, Berlin.
166. Sprecher E. Problematik moderner Drogen: Ginseng - Taigawurzel - Teufelskralle. Schriftenreihe der Bundesapothekerkammer zur wissenschaflichen Fortbildung. Gelbe Reihe. 15:1977;71-95.
167. Subiza J., Subiza J.L., Escribano P.M., Hinojosa M., Garcia R., Jerez M., Subiza E. Occupational asthma caused by Brazil ginseng dust. Journal of Allergy and Clinical Immunology. 88:1991;731-736.
168. Subrahmanyam D., Renuka B., Rao C.V., Sagar P.S., Deevi D.S., Babu J.M., Vyas K. Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents. Bioorganic and Medicinal Chemistry Letters. 8:1998;1391-1396.
169. Sugiyama M., Seki J. In vivo application of lipoproteins as drug carriers: pharmacological evaluation of sterylglucoside-lipoprotein complexes. Targeted Diagnostic Therapy. 5:1991;315-350.
170. Tachikawa E., Kudo K., Kashimoto T., Takahashi E. [Effects of ginseng saponins on receptor stimulation-responses]. Nippon Yakurigaku Zasshi 110 Supplement. 1:1997;126-131. in Japanese with English abstract.
171. Taira J., Ikemoto T., Yoneya T., Hagi A., Murakami A., Makino K. Essential oil phenyl propanoids: useful as OH scavengers? Free Radical Research Communications. 16:1992;197-204.
172. Takemoto T., Nishimoto N., Nakai S., Takagi N., Hayashi S., Odashima S., Wada Y. Pfaffic acid, a novel nortriterpene from Pfaffia paniculata Kuntze. Tetrahedron Letters. 24(10):1983;1057-1060.
173. Thagard P. How Scientists Explain Disease. 1999;Princeton University Press, Princeton, NJ.
174. Tyler V.E. The Honest Herbal. third ed. 1993;Pharmaceutical Products Press, Binghamton, NY.
175. Tyler V.E. Herbs of Choice: The Therapeutic Use of Phytomedicinals. 1994;Pharmaceutical Products Press, Binghamton, NY.
176. Tyring S., Edwards L., Cherry L.K., Ramsell W.M., Kotner S., Greenberg M.D., Vance J.C., Barnum G., Dromgoole S.H., Killey F.P., Toter T. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts. Archives of Dermatology. 134:1998;33-38.
177. US Congress. 103rd Congress, 2nd Session, Senate, 1994. Dietary Supplement Health and Education Act of 1994, pp. 1-39. Public Law 103-417-October 25, 1994. 103 Congress, pp. 4325-4335.
178. Veninga L. The Gingseng Book. 1976;Ruka, Santa Cruz, CA.
179. Vlietinck A.J., De Bruyne T., Apers S., Pieters L.A. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Medica. 64:1998;97-109.
180. Wagner H. Analitik von Eleutherococcus Extrakten. Naturheilpraxis. 8:1980;928-930.
181. Wagner, H., 1987. Immunostimulants from higher plants (recent advances). In: Hostettman, K., Lea, P.J. (Eds.), Biologically Active Natural Products. Proceedings on the Phytochemical Society of Europe 27, 127-141.
182. Wagner, H.K.M., 1995. Immunostimulants and adaptogens from plants. In: Arnason, J.T., Mata, R., Romeo, J.T. (Eds.), Recent Advances in Phytochemistry. Phytochemistry of Medicinal Plants 29, 1-18.
183. Wagner H., Heur Y.H., Obermeler A., Tittel G., Bladt S. Die DC- and HPLC-Analyse der Eleutherococcus Droge. Planta Medica. 44:1982;193-198.
184. Wagner H., Nörr H., Winterhoff H. Plant adaptogens. Phytomedicine. 1:1994;63-76.
185. Wagner von H., Proksch A., Riess-Maurer I., Vollmar A., Odenthal S., Stupper H., Jurcic K., Turdu M., Le Heur Y.H. Immunostimulierend wirkende Polysaccharide (Heteroglykane) aus höheren Pflanzen. Arzneimittelforschung. 34:1984;659-661.
186. Weiss M.G. Karma and Ayurveda. Ancient Science of Life. 6(3):1987;129-134.
187. White D.J., Billingham C., Chapman S., Drake S., Jayaweera D., Jones S., Opaneye A., Temple C. Podophyllin 0.5 or 2.0% v podophyllotoxin 0.5% for the self treatment of penile warts: a double blind randomized study. Genitourinary Medicine. 73:1997;184-187.
188. Wielgorskaya, T., Takhtajan, A. (Eds.), 1995. Dictionary of Generic Names of Seed Plants. Columbia University Press, NY.
189. Williams L.O. Ginseng. Economic Botany. 11:1957;344-348.
190. Williams M.H. Nutrition for Fitness and Sport. fourth ed. 1995;WC Brown Publishers, Dubuque City, IO.
191. Wilson J.D. Vitamin Deficiency and Excess. Fauci A.S., Braunwald E., Isselbacher K.J., Wilson J.D., Martin J.B., Kasper D.L., Hauser S.L., Longo D.L. Harrison's Principals of Internal Medicine. 1998;480-489 McGraw-Hill Health Professions Division, NY.
192. Wittrock, V.B., 1905. Catalogus Illustratus Iconothecae Botanicae Horti Bergiani Stockholmensis, Notulis Biographicis Adjectis. Pars II. Isaac Marcus' Boktryckeri-Aktiebolag, Stockholm. Acta Horti Bergiani Band 3. No. 3.
193. Yamasaki K. Effect of some saponins on glucose transport system. Waller R.G., Yamasaki K. Saponins Used in Traditional and Modern Medicine. 1996;195-206 Plenum Press, London.
194. Yasukawa K., Takido M., Matsumoto T., Takeuchi M., Nakagawa S. Sterol and triterpene derivatives from plants inhibit the effect of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis. Oncology. 48:1991;72-76.
195. Yokozawa T., Liu Z.W., Dong E. A study of ginsenoside-Rd in a renal ischemia-reperfusion model. Nephron. 78:1998;201-206.
196. Yoshimura H., Kimura N., Sugiura K. Preventive effects of various ginseng saponins on the development of copulatory disorder induced by prolonged individual housing in male mice. Methods and Findings in Experimental and Clinical Pharmacology. 20:1998;59-64.
197. Zaricor B. Chinese red: the dawn of mainland ginseng. Whole Foods. 3(2):1980;42-44.
198. Zhao Y.Q. et al. Chemical constituents of Acanthopanax senticosus (Rupr. et Maxim.). Harms Ching Kuo Chung Yao Tsa Chih. 18(7):1993;428-448. in Chinese with English abstract.
199. Ziglar W. The Ziglar Report. An analysis of 54 ginseng products. Whole Foods. 2(4):1979;48-53.
200. Zink T., Chaffin J. Herbal 'health' products: what family physicians need to know. American Family Physician. 58:1998;1133-1140.